Genmab — Januar 2021
-
Ritzau hænger vist lidt i bremsen. https://www.proinvestor.com/investornyt/671453/genmab-darzalex-salg-steg-50-pct-pa-arsbasis-i-december
-
jvf børsen tror citi bank på 4,336 mia. dollar i alt
-
hvoraf 2,255 mia. dollar i USA
-
og konsensus er 4,154 mia. dollar.
-
Novartis presentation: Broad adoption ~1000 patients treated in 1st 4 months
of launch4
, 17% naive5
https://www.novartis.com/sites/www.novartis.com/files/q4-2020-investor-presentation.pdf -
My guess for Q4 will be $610M for US and $625M for ROW. In total it should be very close to the upper band of the guidance of $4.2 billion
-
when we're looking at sales in USD the strength of the Trump USD actually drives up ROW sales...
-
ja - jvf børsen/citi
-
with a little bit of optimism, I'm at Q4 US sales = usd 639m and RoW= usd 650 giving total yearly sales = usd 4.226m
-
in those nos I'm calculating a 15% discount on the US prescription nos
-
jeg kan se, at Verdult hos Citi bruger 90% i sin conversion rate
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind